In summary, given the importance of pathogenic Th17 and nonclassical Th1 cells in RA pathology, VIP is shown as a mediator present in the microenvironment, capable of modulating the pathogenicity of Th17 cells and their Th1 plasticity in RA patients. The gene discussed is VIP; the disease is rheumatoid arthritis.